Determinants of the access to remote specialised services provided by national sarcoma reference centres
-
Published:2021-05-29
Issue:1
Volume:21
Page:
-
ISSN:1471-2407
-
Container-title:BMC Cancer
-
language:en
-
Short-container-title:BMC Cancer
Author:
Fayet YohanORCID, Tétreau Raphaël, Honoré Charles, Le Nail Louis-Romée, Dalban Cécile, Gouin François, Causeret Sylvain, Piperno-Neumann Sophie, Mathoulin-Pelissier Simone, Karanian Marie, Italiano Antoine, Chaigneau Loïc, Gantzer Justine, Bertucci François, Ropars Mickael, Saada-Bouzid Esma, Cordoba Abel, Ruzic Jean-Christophe, Varatharajah Sharmini, Ducimetière Françoise, Chabaud Sylvie, Dubray-Longeras Pascale, Fiorenza Fabrice, De Percin Sixtine, Lebbé Céleste, Soibinet Pauline, Michelin Paul, Rios Maria, Farsi Fadila, Penel Nicolas, Bompas Emmanuelle, Duffaud Florence, Chevreau Christine, Le Cesne Axel, Blay Jean-Yves, Le Loarer François, Ray-Coquard Isabelle
Abstract
Abstract
Background
Spatial inequalities in cancer management have been evidenced by studies reporting lower quality of care or/and lower survival for patients living in remote or socially deprived areas. NETSARC+ is a national reference network implemented to improve the outcome of sarcoma patients in France since 2010, providing remote access to specialized diagnosis and Multidisciplinary Tumour Board (MTB). The IGéAS research program aims to assess the potential of this innovative organization, with remote management of cancers including rare tumours, to go through geographical barriers usually impeding the optimal management of cancer patients.
Methods
Using the nationwide NETSARC+ databases, the individual, clinical and geographical determinants of the access to sarcoma-specialized diagnosis and MTB were analysed. The IGéAS cohort (n = 20,590) includes all patients living in France with first sarcoma diagnosis between 2011 and 2014. Early access was defined as specialised review performed before 30 days of sampling and as first sarcoma MTB discussion performed before the first surgery.
Results
Some clinical populations are at highest risk of initial management without access to sarcoma specialized services, such as patients with non-GIST visceral sarcoma for diagnosis [OR 1.96, 95% CI 1.78 to 2.15] and MTB discussion [OR 3.56, 95% CI 3.16 to 4.01]. Social deprivation of the municipality is not associated with early access on NETSARC+ remote services. The quintile of patients furthest away from reference centres have lower chances of early access to specialized diagnosis [OR 1.18, 95% CI 1.06 to 1.31] and MTB discussion [OR 1.24, 95% CI 1.10 to 1.40] but this influence of the distance is slight in comparison with clinical factors and previous studies on the access to cancer-specialized facilities.
Conclusions
In the context of national organization driven by reference network, distance to reference centres slightly alters the early access to sarcoma specialized services and social deprivation has no impact on it. The reference networks’ organization, designed to improve the access to specialized services and the quality of cancer management, can be considered as an interesting device to reduce social and spatial inequalities in cancer management. The potential of this organization must be confirmed by further studies, including survival analysis.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference39 articles.
1. Frezza AM, Trama A, Blay J-Y, Casali PG. Networking in rare cancers: what was done, what’s next. Eur J Surg Oncol. 2019;45(1):16–8. https://doi.org/10.1016/j.ejso.2018.03.030. 2. Sandrucci S, Gatta G. Rare cancers: a network for better care. Eur J Surg Oncol. 2019;45(1):1–2. https://doi.org/10.1016/j.ejso.2018.06.028. 3. Casali PG. Rare cancers: from centralized referral to networking. Ann Oncol. 2019;30(7):1037–8. 4. Amadeo B, Penel N, Coindre J-M, Ray-Coquard I, Ligier K, Delafosse P, et al. Incidence and time trends of sarcoma (2000–2013): results from the French network of cancer registries (FRANCIM). BMC Cancer. 2020;20(1):190. https://doi.org/10.1186/s12885-020-6683-0. 5. de Pinieux G, Karanian M, Le Loarer F, Le Guellec S, Chabaud S, Terrier P, et al. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network. PLoS One. 2021;16(2):e0246958.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|